CD86-based analysis enables observation of bona fide hematopoietic responses

25Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hematopoiesis is a system that provides red blood cells (RBCs), leukocytes, and platelets, which are essential for oxygen transport, biodefense, and hemostasis; its balance thus affects the outcome of various disorders. Here, we report that stem cell antigen-1 (Sca-1), a cell surface marker commonly used for the identification of multipotent hematopoietic progenitors (Lin2Sca-11c-Kit1 cells; LSKs), is not suitable for the analysis of hematopoietic responses under biological stresses with interferon production. Lin2Sca-1-c-Kit1 cells (LKs), downstream progenitors of LSKs, acquire Sca-1 expression upon inflammation, which makes it impossible to distinguish between LSKs and LKs. As an alternative and stable marker even under such stresses, we identified CD86 by screening 180 surface markers. The analysis of infection/inflammation-triggered hematopoiesis on the basis of CD86 expression newly revealed urgent erythropoiesis producing stress-resistant RBCs and intact reconstitution capacity of LSKs, which could not be detected by conventional Sca-1–based analysis. (Blood. 2020; 136(10):1144-1154)

Cite

CITATION STYLE

APA

Kanayama, M., Izumi, Y., Yamauchi, Y., Kuroda, S., Shin, T., Ishikawa, S., … Ohteki, T. (2020). CD86-based analysis enables observation of bona fide hematopoietic responses. Blood, 136(10), 1144–1154. https://doi.org/10.1182/blood.2020004923

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free